DPI & Amethis’s investment in Marcyrl Pharmaceutical’s operations in Egypt

Lead party: Development Partners International (DPI) (investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Marcyrl Pharmaceutical Industries (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Egypt Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Equity · Fund: African Development Partners III…


Lead party: Development Partners International (DPI) (investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Marcyrl Pharmaceutical Industries (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Egypt

Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Equity · Fund: African Development Partners III (ADP III)

Investors/buyers: Development Partners International (DPI), Amethis Investment Fund Manager S.A.

Legal advisers: not identified in the source record.

Source: announced 4 April 2023. Original announcement: amethis.com.